Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Kanghua Healthcare to Raise $154 Million in Hong Kong IPO (in: Deals & Financings)
  Pluristem to Raise $30 Million from China's Innovative Medical (in: Deals & Financings)
  Athenex to Market Five Oncology Products from Beijing Sciecure in US (in: Deals & Financings)
  Biohit Oyj OK'd to Start China Production of Cancer Screening Test (in: Trials & Approvals)
  CFDA Addresses "80% of China Trials are Based on Fraudulent Data" Story (in: Trials & Approvals)
  Yisheng Granted US Orphan Drug Designation for Cancer Immunotherapy (in: Trials & Approvals)
  Week in Review: Over $850M in China Healthcare and Pharma Deals (in: Week in Review)
  Luye Medical Offers $91 Million for Australian Hospital Chain (in: Deals & Financings)
  MicuRx Starts China Phase III Trial of Novel Antibiotic (in: Trials & Approvals)
  Tamasek Invests $250 Million in Columbia Pacific for China Hospitals (in: Deals & Financings)